Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies.
Lilyana AmezcuaYang Mao-DraayerWendy S VargasRebecca FarberSara SchaeferFilipe BrancoSarah M EnglandNicholas BelvisoJames B LewinJason P MendozaSai L Shankarnull nullPublished in: Neurology and therapy (2023)
Clinical trials.gov, DEFINE (NCT00420212), CONFIRM (NCT00451451), and ENDORSE (NCT00835770).